Virginia Retirement Systems’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $453K | Sell |
9,736
-1,600
| -14% | -$76.8K | ﹤0.01% | 989 |
|
|
2026
Q1 | $586K | Sell |
11,336
-7,000
| -38% | -$356K | ﹤0.01% | 724 |
|
|
2025
Q4 | $911K | Sell |
18,336
-9,900
| -35% | -$481K | 0.01% | 618 |
|
|
2025
Q3 | $1.35M | Sell |
28,236
-20,500
| -42% | -$826K | 0.01% | 504 |
|
|
2025
Q2 | $1.54M | Buy |
48,736
+19,000
| +64% | +$609K | 0.01% | 461 |
|
|
2025
Q1 | $974K | Buy |
+29,736
| New | +$1.05M | 0.01% | 563 |
|
|
2023
Q3 | $562K | Buy |
20,400
+2,000
| +11% | +$60.9K | 0.01% | 661 |
|
|
2023
Q2 | $553K | Buy |
+18,400
| New | +$644K | 0.01% | 700 |
|
|
2022
Q1 | – | Sell |
-12,600
| Closed | -$367K | – | 1212 |
|
|
2021
Q4 | $367K | Sell |
12,600
-10,700
| -46% | -$325K | ﹤0.01% | 937 |
|
|
2021
Q3 | $621K | Sell |
23,300
-5,500
| -19% | -$148K | 0.01% | 755 |
|
|
2021
Q2 | $887K | Sell |
28,800
-2,300
| -7% | -$70.5K | 0.01% | 688 |
|
|
2021
Q1 | $814K | Sell |
31,100
-4,200
| -12% | -$117K | 0.01% | 725 |
|
|
2020
Q4 | $888K | Sell |
35,300
-4,000
| -10% | -$86.1K | 0.01% | 643 |
|
|
2020
Q3 | $819K | Sell |
39,300
-1,300
| -3% | -$29.5K | 0.01% | 598 |
|
|
2020
Q2 | $964K | Sell |
40,600
-3,900
| -9% | -$86.2K | 0.01% | 572 |
|
|
2020
Q1 | $801K | Hold |
44,500
| – | – | 0.01% | 629 |
|
|
2019
Q4 | $1.06M | Buy |
44,500
+100
| +0.2% | +$2.43K | 0.01% | 669 |
|
|
2019
Q3 | $1.22M | Buy |
44,400
+18,700
| +73% | +$554K | 0.01% | 605 |
|
|
2019
Q2 | $850K | Sell |
25,700
-8,400
| -25% | -$288K | 0.01% | 725 |
|
|
2019
Q1 | $1.2M | Buy |
34,100
+1,600
| +5% | +$59.5K | 0.01% | 607 |
|
|
2018
Q4 | $1.08M | Buy |
32,500
+16,000
| +97% | +$688K | 0.01% | 593 |
|
|
2018
Q3 | $831K | Sell |
16,500
-6,300
| -28% | -$311K | 0.01% | 767 |
|
|
2018
Q2 | $1.36M | Sell |
22,800
-6,900
| -23% | -$357K | 0.02% | 577 |
|
|
2018
Q1 | $1.36M | Sell |
29,700
-17,000
| -36% | -$709K | 0.02% | 557 |
|
|
2017
Q4 | $1.86M | Sell |
46,700
-5,300
| -10% | -$209K | 0.02% | 493 |
|
|
2017
Q3 | $2.08M | Sell |
52,000
-16,200
| -24% | -$701K | 0.03% | 489 |
|
|
2017
Q2 | $2.94M | Sell |
68,200
-3,600
| -5% | -$128K | 0.04% | 378 |
|
|
2017
Q1 | $2.25M | Buy |
71,800
+10,500
| +17% | +$281K | 0.03% | 445 |
|
|
2016
Q4 | $1.55M | Buy |
61,300
+4,300
| +8% | +$96.1K | 0.02% | 471 |
|
|
2016
Q3 | $1.41M | Buy |
57,000
+45,500
| +396% | +$1.03M | 0.02% | 474 |
|
|
2016
Q2 | $234K | Buy |
+11,500
| New | +$204K | ﹤0.01% | 875 |
|
Other funds holding SUPN
AC
NAMI
SIMG
Virginia Retirement Systems's SUPN Position: Q2 2026 in Review
Virginia Retirement Systems reduced its Supernus Pharmaceuticals (SUPN) stake by 14% in Q2 2026, selling an estimated $76.8K and leaving 9,736 shares worth $453K. The position accounts for ﹤0.01% of the portfolio, ranked #989.
Virginia Retirement Systems first reported a position in SUPN in Q2 2016 and has held it in 31 quarters since. The position peaked at $2.94M in Q2 2017. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- Virginia Retirement Systems held 9,736 shares of Supernus Pharmaceuticals worth $453K as of Q2 2026.
- Virginia Retirement Systems sold 1,600 Supernus Pharmaceuticals shares in Q2 2026, an estimated $76.8K.
- Supernus Pharmaceuticals made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #989 holding.
- Virginia Retirement Systems first reported a position in Supernus Pharmaceuticals in Q2 2016 and has held it in 31 quarters since.
- Virginia Retirement Systems's Supernus Pharmaceuticals position peaked at $2.94M in Q2 2017.
- 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.